Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Demyelination: the role of reactive oxygen and nitrogen species.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Phase IV Study Reports Multiple Sclerosis Success with Teriflunomide
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Tysabri
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Amiloride HCI Tablets, USP 5 mg
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
High dose naltrexone for dyskinesias induced by levodopa.

Pages